Cargando…
Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination
Human iPS cells hold great promise for disease modeling and treatment of degenerative disorders including muscular dystrophies. Although a few research groups have used them for skeletal muscle differentiation, most were based on gene over-expression or long-term mesenchymal differentiation and retr...
Autores principales: | Wu, Jianbo, Hunt, Samuel D., Xue, Haipeng, Liu, Ying, Darabi, Radbod |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700424/ https://www.ncbi.nlm.nih.gov/pubmed/26729410 http://dx.doi.org/10.1038/srep18759 |
Ejemplares similares
-
Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system
por: Romano, Elena, et al.
Publicado: (2021) -
Mutagenesis and homologous recombination in Drosophila cell lines using CRISPR/Cas9
por: Bassett, Andrew R., et al.
Publicado: (2013) -
Successful CRISPR/Cas9 mediated homologous recombination in a chicken cell line
por: Antonova, Ekaterina, et al.
Publicado: (2018) -
A Perspective on the Potential of Human iPS Cell-Based Therapies for Muscular Dystrophies: Advancements so far and Hurdles to Overcome
por: Darabi, Radbod, et al.
Publicado: (2013) -
Targeted recombination of homologous chromosomes using CRISPR‐Cas9
por: Son, Wonseok, et al.
Publicado: (2023)